Amyloidosis Information: A General Overview for Patients | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Amyloidosis Information: A General Overview for Patients

key information

source: Amyloidosis Foundation

year: 2020

summary/abstract:

The amyloidoses (the plural word for amyloidosis) are rare diseases first described over 150 years ago. There are different types of amyloidosis that are all unified by a common pathological process. Amyloid diseases all cause deposits of amyloid proteins in the body’s organs and tissue, and the amyloidoses are classified by the protein that deposits as amyloid. This accumulation may happen systemically (throughout the body) or locally (in one tissue or organ).

Each year approximately 3000-5000 new cases of light chain (AL) amyloidosis are diagnosed in the United States, with many more cases of age-related and inherited transthyretin amyloidosis (ATTR) also diagnosed. Amyloidosis is generally a disease of middle-aged people and older, although the disease has been seen in individuals in their thirties.

Other diseases can increase the risk of amyloidosis, and family history of the disease may indicate a hereditary version. 10 to 15% of people with multiple myeloma develop amyloidosis. Long-term kidney dialysis may increase the risk of dialysis-associated amyloidosis.

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close